55
Participants
Start Date
July 31, 2012
Primary Completion Date
May 31, 2016
Study Completion Date
December 31, 2016
fludarabine
30 mg/m2/day intravenously on days 1 to 4
Idarubicin
10 mg/m2/day intravenously on days 1 to 3
cytarabine
2 g/m2/day intravenously on days 1 to 4
G-CSF
5 μg/kg/day subcutaneously from days 1 to 4
plerixafor
intravenously from days 1 to 4
Hospital Universitari Germans Trials i Pujol, Badalona
Hospital Clínic de Barcelona, Barcelona
Hospital de la Santa Creu i Sant Pau., Barcelona
Hospital Duran i Reynals - ICO L'Hospitalet, Barcelona
Hospital Universitario Vall d'Hebron, Barcelona
Hospital Universitario Reina Sofía, Córdoba
Hospital Clínico San Carlos, Madrid
Hospital Universitario 12 de Octubre, Madrid
Hospital Clínico Universitario de Salamanca, Salamanca
Hospital Universitari La Fe, Valencia
PETHEMA Foundation
OTHER